Anbio Biotechnology (NNNN) Assets Average (2024 - 2025)

Anbio Biotechnology has reported Assets Average over the past 2 years, most recently at $24.6 million for Q4 2025.

  • Quarterly results put Assets Average at $24.6 million for Q4 2025, up 41.55% from a year ago — trailing twelve months through Dec 2025 was $24.6 million (up 41.55% YoY), and the annual figure for FY2025 was $24.6 million, up 41.55%.
  • Assets Average for Q4 2025 was $24.6 million at Anbio Biotechnology, up from $17.4 million in the prior quarter.
  • Over the last five years, Assets Average for NNNN hit a ceiling of $24.6 million in Q4 2025 and a floor of $17.4 million in Q4 2024.